Can a text message boost flu shot rates?
Part of Infections, Lungs & breathing clinical trials.
This trial sends a text message to people 65 or older in Norway to see if it encourages them to get the 2025 flu vaccine. It aims to find simple ways to increase vaccination coverage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years or older (born in 1960 or earlier).
- You must live in Norway with a valid ID number as of September 1, 2025.
- You must have a registered mobile phone number to receive the text.
- You cannot have already received the 2025 flu vaccine before the text is sent.
- You must not have moved away from Norway or passed away before the text is sent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This trial tests a flu vaccine (split virus type) for adults aged 60+ to see how well it works and how safe it is. It might help protect older adults from the flu.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This trial looks at an organized plan to give flu vaccines during hospital stays. It may help more inpatients get protected against influenza before they leave the hospital.
This trial tests if text message reminders help adults turning 65 in Chile get their pneumococcal vaccine. If you are turning 65 in 2026 and live in Chile, this study may be for you.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.